By application, neuropathic pain is expected to lead the market ... and this expansion can be attributed to R&D investments in the development of technologically advanced healthcare treatment options.
Neuropathic pain is a chronic and debilitating condition that impacts around 10% of the population in both the United States and Europe. Despite advances in understanding the mechanisms of neuropathic ...